Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120
- PMID: 2006155
- PMCID: PMC51195
- DOI: 10.1073/pnas.88.6.2189
Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120
Abstract
Human immunodeficiency virus (HIV) infects cells after binding of the viral envelope glycoprotein gp120 to the cell surface recognition marker CD4. gp120 is noncovalently associated with the HIV transmembrane envelope glycoprotein gp41, and this complex is believed responsible for the initial stages of HIV infection and cytopathic events in infected cells. Soluble constructs of CD4 that contain the gp120 binding site inhibit HIV infection in vitro. This is believed to occur by competitive inhibition of viral binding to cellular CD4. Here we suggest an alternative mechanism of viral inhibition by soluble CD4 proteins. We demonstrate biochemically and morphologically that following binding, the soluble CD4 proteins sT4, V1V2,DT, and V1[106] (amino acids 1-369, 1-183, and -2 to 106 of mature CD4) induced the release of gp120 from HIV-1 and HIV-1-infected cells. gp120 release was concentration-, time-, and temperature-dependent. The reaction was biphasic at 37 degrees C and did not take place at 4 degrees C, indicating that binding of soluble CD4 was not sufficient to release gp120. The appearance of free gp120 in the medium after incubation with sT4 correlated with a decrease in envelope glycoprotein spikes on virions and exposure of a previously cryptic epitope near the amino terminus of gp41 on virions and infected cells. The concentration of soluble CD4 proteins needed to induce the release of gp120 from virally infected cells also correlated with those required to inhibit HIV-mediated syncytium formation. These results suggest that soluble CD4 constructs may inactivate HIV by inducing the release of gp120. We propose that HIV envelope-mediated fusion is initiated following rearrangement and/or dissociation of gp120 from the gp120-gp41 complex upon binding to cellular CD4, thus exposing the fusion domain of gp41.
Similar articles
-
Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.J Exp Med. 1991 Aug 1;174(2):407-15. doi: 10.1084/jem.174.2.407. J Exp Med. 1991. PMID: 1713252 Free PMC article.
-
CD4 activation of HIV fusion.Int J Cell Cloning. 1992 Nov;10(6):323-32. doi: 10.1002/stem.5530100603. Int J Cell Cloning. 1992. PMID: 1281202 Review.
-
Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.J Virol. 1992 Sep;66(9):5516-24. doi: 10.1128/JVI.66.9.5516-5524.1992. J Virol. 1992. PMID: 1501286 Free PMC article.
-
Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies.J Virol. 1995 Jul;69(7):4267-73. doi: 10.1128/JVI.69.7.4267-4273.1995. J Virol. 1995. PMID: 7769687 Free PMC article.
-
The role of CD4 in HIV binding and entry.Philos Trans R Soc Lond B Biol Sci. 1993 Oct 29;342(1299):59-66. doi: 10.1098/rstb.1993.0136. Philos Trans R Soc Lond B Biol Sci. 1993. PMID: 7904348 Review.
Cited by
-
Identification and characterization of an immunogenic hybrid epitope formed by both HIV gp120 and human CD4 proteins.J Virol. 2011 Dec;85(24):13097-104. doi: 10.1128/JVI.05072-11. Epub 2011 Oct 12. J Virol. 2011. PMID: 21994452 Free PMC article.
-
Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions.J Virol. 1993 Aug;67(8):4557-65. doi: 10.1128/JVI.67.8.4557-4565.1993. J Virol. 1993. PMID: 8331723 Free PMC article.
-
Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor.J Virol. 1997 Feb;71(2):883-90. doi: 10.1128/JVI.71.2.883-890.1997. J Virol. 1997. PMID: 8995604 Free PMC article.
-
Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91. doi: 10.1073/pnas.93.5.2186. Proc Natl Acad Sci U S A. 1996. PMID: 8700906 Free PMC article.
-
gp120-derived amyloidogenic peptides form amyloid fibrils that increase HIV-1 infectivity.Cell Mol Immunol. 2024 May;21(5):479-494. doi: 10.1038/s41423-024-01144-y. Epub 2024 Mar 5. Cell Mol Immunol. 2024. PMID: 38443447
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials